• ZDHHC2-Mediated Autophagic Degradation Regulates Macrophage

  2026-05-12

  This study uncovers the role of ZDHHC2, a palmitoyltransferase, in promoting antimycobacterial immunity by targeting B-RAF and C-RAF for selective autophagic degradation in macrophages. The findings establish a novel regulatory axis linking protein palmitoylation, autophagic flux, and MAPK signaling in host defense against Mycobacterium tuberculosis.

• Amikacin Sulfate: Protocol Optimization for Mycobacterial Re

  2026-05-12

  Amikacin Sulfate empowers researchers to tackle non-tuberculous mycobacterial infections through precise intracellular delivery and robust bactericidal activity. This guide delivers actionable protocols, troubleshooting insights, and data-driven workflow enhancements using validated APExBIO Amikacin Sulfate.

• CRISPRa Enables Splicing Variant Analysis in Accessible Cell

  2026-05-11

  Terkelsen et al. introduce a CRISPR activation (CRISPRa) method to upregulate disease-relevant genes in skin fibroblasts, allowing functional assessment of splice-altering variants even when native expression is tissue-restricted. This approach offers a practical advance for rare disease diagnostics, overcoming previous limitations in transcriptome-based variant interpretation.

• Cy5-UTP: Precision RNA Probe Synthesis for Advanced FISH

  2026-05-11

  Cy5-UTP (Cyanine 5-uridine triphosphate) unlocks robust, direct fluorescent RNA labeling for in vitro transcription workflows. Its orange-red emission and high incorporation efficiency enable seamless probe generation for FISH, multiplexed expression arrays, and nanoparticle tracking—streamlining both visualization and quantitation.

• Clinical Complexity of Prochlorperazine-Induced Neuroleptic

  2026-05-10

  This article analyzes a recent case report detailing neuroleptic malignant syndrome (NMS) triggered by prochlorperazine in an elderly patient. The study highlights diagnostic challenges when classic laboratory markers are absent and underscores the importance of meticulous clinical assessment and prompt intervention for drug-induced NMS.

• Lamotrigine in Translational Neuro-Cardiac Signaling Researc

  2026-05-09

  Explore how Lamotrigine enables advanced research into sodium channel and serotonin pathway modulation. This article offers a distinct, cross-domain perspective on Lamotrigine's mechanism and assay design for neurological and cardiac studies.

• Quizartinib (AC220): Mechanistic Precision in AML Research

  2026-05-09

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Quizartinib (AC220) in acute myeloid leukemia (AML) research. By integrating recent insights into FLT3 signaling, resistance mechanisms, and selective cell death pathways, we provide a strategic guide for researchers aiming to bridge preclinical validation with clinical innovation. The discussion situates Quizartinib within the evolving landscape of targeted therapies, highlighting practical assay parameters, competitive differentiation, and the future trajectory of FLT3 inhibition strategies. The article is designed for translational scientists, offering actionable recommendations supported by quantitative data and authoritative citations.

• Tetramethylrhodamine Ethyl Ester Perchlorate in Mitochondria

  2026-05-08

  Tetramethylrhodamine ethyl ester perchlorate (TMRE) empowers sensitive, quantitative live-cell assessment of mitochondrial membrane potential. Its robust fluorescence and low cytotoxicity make it the gold-standard for dissecting mitochondrial dysfunction and oxidative stress in disease models.

• PBS Liposomes: Optimizing Controls in Macrophage Depletion A

  2026-05-07

  PBS Liposomes deliver unmatched specificity as inert, gold-standard controls for macrophage depletion studies by ensuring that observed effects stem solely from experimental variables. Their robust uptake and non-cytotoxic profile streamline reproducibility, while precise experimental parameters further enhance assay reliability.

• Rosiglitazone (Brl-49653): Optimizing PPARγ Activation in Re

  2026-05-07

  Rosiglitazone (Brl-49653) is a gold-standard PPARγ agonist that unlocks robust adipogenesis, insulin sensitivity studies, and metabolic signaling assays. This guide translates bench research and recent breakthroughs—like SEMA3E-driven beige adipocyte differentiation—into actionable workflows and troubleshooting tips for advanced type II diabetes and metabolic disorder research.

• BKT140 (BL-8040): CXCR4 Antagonist for Precision Oncology Re

  2026-05-06

  Discover how BKT140 (BL-8040) CXCR4 antagonist reshapes tumor progression and apoptosis research, with a focus on assay design, translational impact, and practical workflow considerations—grounded in the latest theranostic insights.

• AZ505, a Potent and Selective SMYD2 Inhibitor in Cell Assays

  2026-05-06

  This article explores common challenges in epigenetic and cancer biology assays, offering practical, scenario-driven guidance for using AZ505, a potent and selective SMYD2 inhibitor (SKU B1255). Integrating peer-reviewed evidence and validated workflows, it demonstrates how AZ505 enhances reproducibility and data integrity for biomedical researchers.

• Tofacitinib (CP-690550): JAK1/JAK3 Inhibition & Immune Modul

  2026-05-05

  Tofacitinib (CP-690550) is a potent oral Janus kinase inhibitor with selectivity for JAK1 and JAK3, enabling precise inhibition of interleukin signaling and lymphocyte activation. Its efficacy in modulating GM-CSF-driven inflammation and mitochondrial repair in rheumatoid arthritis models is supported by quantitative in vitro and in vivo studies.

• Enhanced Cell Proliferation Analysis with EdU Imaging Kits (

  2026-05-05

  Discover how EdU Imaging Kits (488) (SKU K1175) provide reliable, reproducible S-phase DNA synthesis measurement in cell proliferation assays. This article addresses real laboratory challenges and presents evidence-driven solutions for optimizing workflow, sensitivity, and data quality using click chemistry-based EdU detection.

• Lactate-Driven Ran Lactylation Regulates Astrocyte Polarizat

  2026-05-04

  This study uncovers that lactate accumulation following spinal cord injury promotes astrocyte polarization through SIRT1-regulated lactylation of the non-histone protein Ran at lysine 123. These findings provide a mechanistic link between metabolic stress, epigenetic modification, and astrocyte function, offering new insights for CNS injury research and potential therapeutic targeting.

460 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page